Welcome to our dedicated page for Sparta Cap news (Ticker: SCAXF), a resource for investors and traders seeking the latest updates and insights on Sparta Cap stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Sparta Cap's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Sparta Cap's position in the market.
Sparta Group (OTC PINK: SCAXF) has requested an extension from the Alberta Securities Commission (ASC) to file its Annual Filings due to delays in the audit process, attributed to staffing issues within the audit firm. The deadline for these filings has been pushed to April 5, 2023. An ongoing Management Cease Trade Order (MCTO) restricts trading for the CEO and CFO until the filings are completed. The company confirmed no significant business developments or insolvency proceedings since its last interim report, as it aims to comply with the Alternative Information Guidelines during this period.
Sparta Group (OTC PINK:SCAXF) announced it is seeking an extension from the Alberta Securities Commission (ASC) to file its Annual Filings for the year ended September 30, 2022, due to ongoing auditor delays. The management cease trade order (MCTO) will remain in effect until the filings are completed, expected by April 5, 2023. The delays are attributed to staffing issues at the auditing firm. Despite these challenges, Sparta confirms no material business developments or insolvency proceedings have occurred since its last interim financial report. The company continues to operate under the Alternative Information Guidelines during this period.
Sparta Capital Ltd. announced a private placement of unsecured convertible debentures to raise up to $500,000 for its partnership with SBL Testing Technologies. The proceeds will support the marketing of rapid-testing solutions across North America and the Caribbean amidst the ongoing COVID-19 pandemic. Each debenture, priced at $5,000, will carry an 8% interest rate, maturing in 2 years. Holders can convert debentures into shares and warrants at varying prices based on conversion timing. The placement is expected to close around November 5, 2021.
Concordia University has partnered with Sparta Group to implement the CASPR (Continuous Air and Surface Pathogen Reduction) system aimed at enhancing COVID-19 safety measures. The CASPR technology, which reduces pathogens by 99.96%, will be installed in high-traffic areas of the campus. This initiative, part of a pilot project, could lead to further orders if initial tests are successful. The installation signifies a proactive approach to health and safety amidst ongoing pandemic concerns.